News
As a veteran academic researcher, department chairperson and associate dean for research, I have seen this process play out from multiple perspectives – as a grant recipient, grant reviewer and ...
The final vote to pass the “One Big Beautiful Bill Act” has been scheduled to take place sometime between 5 and 6 a.m.
confidentiality from employees, former employees, suppliers, customers, visitors, etc. that have access to, or obtained, a trade secret; (3) restricting visitors from, or applying differentiated ...
(One specific gripe was that one commenter called him a “predator.”) Also, Hudson was on the field during the final spring practice. And not with a friends-and-family sideline pass. She was working.
If your company has been sued for trade secret misappropriation, you are not without options. Trade secret litigation can move quickly and carry ...
Shane Croucher is a Breaking News Editor based in London, UK. He has previously overseen the My Turn, Fact Check and News teams, and was a Senior Reporter before that, mostly covering U.S. news ...
On April 1, 2025, the Act to Strengthen Germany as a Location for Justice—formally titled Justizstandort-Stärkungsgesetz of October 7, 2024 (Federal Law Gazette 2024 I No. 302)—entered into force.
Vietnam signs nuclear power agreement as it seeks to rebalance US trade (AI image) The Vietnamese team had also entered the second round of trade negotiations on Tuesday, it said.Both sides "spent ...
3d
The Kyiv Independent on MSNZelensky proposes free trade agreement to Trump, Kyiv saysPresident Volodymyr Zelensky has proposed a free trade agreement between Ukraine and the U.S. to President Donald Trump, ...
3d
Ukrainska Pravda on MSNZelenskyy proposes free trade agreement with US, details unveiledPresident Volodymyr Zelenskyy has proposed concluding a free trade agreement with the United States in a letter to US ...
U.S. drugmaker Pfizer said it would license an experimental cancer treatment from China's 3SBio Inc , paying $1.25 billion ...
A multibillion-dollar partnership between AbbVie and Genmab risks being soured by a lawsuit claiming misappropriation of trade secrets. Specifically, it focuses on the use of disaccharides to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results